Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 8, 2023.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
The professor of neurology at Johns Hopkins University School of Medicine discussed the traditional view of epilepsy treatment and how the paradigm has shifted to provide new treatments to achieve seizure freedom for drug-resistant patients. [WATCH TIME: 5 minutes]
The division chief of pediatric neurosurgery at Ann & Robert H. Lurie Children's Hospital of Chicago talked about findings from a recently published study on long-term survival of pediatric patients with drug-resistant epilepsy which was presented at AES 2023. [WATCH TIME: 6 minutes]
In this edition of NeuroVoices, the vice president of the Rare Disease Translational Center at the Jackson Laboratory provided context on a recently published study suggesting restoration of stathmin-2 as a therapeutic approach for ALS.
In this Peer Exchange episode of the "Novel Mechanisms of Action in Multiple Sclerosis: Focus on BTK Inhibitors" video series, experts provide insights about what clinical measures they look for when treating patients with BTKis for multiple sclerosis.
In this NeurologyLive Insights episode of the "An Expert Approach to Navigating the Complexities of Huntington’s Disease," video series, Daniel Claassen, MD, MS, provides an overview of the pathophysiology and genetic background of Huntington’s disease (HD), a neurodegenerative disorder.